Aurora Analytica

Norway
Oslo, Oslo, Norway, 1169

Company profile

Aurora Analytica company profile

Founded in February 2023 and incorporated in January 2024, Aurora Analytica is a pioneering health technology company dedicated to optimizing the clinical trial lifecycle and accelerating the development of new treatment options. Our AI-powered platform provides strategic insights, site intelligence, and data-driven tools that enable biotech and pharmaceutical companies to design faster, smarter trials. A single platform that brings together essential assessments, the Aurora Suite™ consists of eleven interconnected modules that function collaboratively within a comprehensive analytics environment. Built on over 30 years of industry expertise, Aurora Analytica bridges the gap between innovation and execution—reducing costs, improving accuracy, and ultimately helping bring better therapies to patients, faster.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Founded
2024-01-01

Headquarters

Headquarters
Oslo, Oslo, Norway
Postal code
1169
Country code
NO
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
5
Total equity funding
$274,323
Last funding
Grant / $49,867 / 2025-10-22
Last equity funding
Pre Seed / $29,865
Investors
4
Lead investors
3
Founders
2
Articles
14

Founders and investors

Founders

Bhavish LekhOla Gudmundsen

Lead investors

ERM InvestH2O Holding ASInnovation Norway

Investors

ERM InvestH2O Holding ASInnovation NorwayLekh Corp AS